Home » Topics » BioWorld Science

BioWorld Science
RSS

U7-snRNA therapy targeting the DUX4 gene developed for facioscapulohumeral muscular dystrophy

May 31, 2018

Japanese researchers divulge RDH10 inhibitors

May 31, 2018

Researchers from U.S. patent 5-HT1F receptor agonists

May 31, 2018

Academia and industry establish immune-mediated inflammatory diseases consortium

May 31, 2018

Kissei announces negative topline results from the additional phase III study of KPS-0373

May 31, 2018

ConSynance announces initiation of toxicology studies of CSTI-300 for IBS-D

May 31, 2018

DSMB clears phase II trial of AG-013 for oral mucositis to continue

May 30, 2018

FDA grants priority review to Sage's NDA for intravenous brexanolone for postpartum depression

May 30, 2018

Atox initiates phase II trial of reltecimod in acute kidney injury

May 30, 2018

FDA approves Imvexxy to treat moderate to severe dyspareunia due to menopause

May 30, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
Next wave of BCI firms builds on pioneers to tackle challenges
BioWorld
With the pace of neurotechnology development accelerating, a wave of brain-computer interface (BCI) companies is emerging on the heels of the pioneers. In the...
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
Boehringer Ingelheim identifies new mGlu3 receptor agonists
BioWorld Science
Boehringer Ingelheim Pharma GmbH & Co. KG and Vanderbilt University have discovered new dihydrobenzoxazine compounds acting as metabotropic glutamate mGlu3...